Personal information

Australia

Activities

Employment (1)

Therapeutic Goods Administration: Melbourne, AU

2013-01 to present | Medical Officer
Employment
Source: Self-asserted source
Sarah Golding

Education and qualifications (2)

Australian National University: Canberra, ACT, AU

2007 to 2010 | Bachelor of Medicine/Bachelor of Surgery
Education
Source: Self-asserted source
Sarah Golding

Monash University: Clayton, VIC, AU

2003 to 2006 | BBiomedSci (Hon)
Education
Source: Self-asserted source
Sarah Golding

Works (4)

FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis

Clinical Cancer Research
2020-10-01 | Journal article
Contributors: Shaily Arora; Sanjeeve Balasubramaniam; Wei Zhang; Lijun Zhang; Rajeshwari Sridhara; Dianne Spillman; Jaigi P. Mathai; Bradley Scott; Sarah J. Golding; Michael Coory et al.
Source: check_circle
Crossref

Fast-track pathways for drug approvals: the Australian experience so far.

Australian prescriber
2019-08 | Journal article
Contributors: Bootes A; Maundu J; Golding S; McDonald M; Lombard J
Source: Self-asserted source
Sarah Golding via Europe PubMed Central

Conformational change in the chromatin remodelling protein MENT.

PloS one
2009-03 | Journal article
Contributors: Ong PC; Golding SJ; Pearce MC; Irving JA; Grigoryev SA; Pike D; Langendorf CG; Bashtannyk-Puhalovich TA; Bottomley SP; Whisstock JC et al.
Source: Self-asserted source
Sarah Golding via Europe PubMed Central

Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase.

Proceedings of the National Academy of Sciences of the United States of America
2009-02 | Journal article
Contributors: McGowan S; Porter CJ; Lowther J; Stack CM; Golding SJ; Skinner-Adams TS; Trenholme KR; Teuscher F; Donnelly SM; Grembecka J et al.
Source: Self-asserted source
Sarah Golding via Europe PubMed Central